Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry

被引:19
|
作者
Villanueva, Josep [1 ,2 ]
Nazarian, Arpi [1 ]
Lawlor, Kevin [1 ]
Tempst, Paul [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Prot Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
CANCER; PROTEASES; PATTERNS;
D O I
10.1038/nprot.2009.88
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Measuring enzymatic activities in biological fluids is a form of activity-based proteomics and may be utilized as a means of developing disease biomarkers. Activity-based assays allow amplification of output signals, thus potentially visualizing low-abundant enzymes on a virtually transparent whole-proteome background. The protocol presented here describes a semiquantitative in vitro assay of proteolytic activities in complex proteomes by monitoring breakdown of designer peptide substrates using robotic extraction and a matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometric readout. Relative quantitation of the peptide metabolites is carried out by comparison with spiked internal standards, followed by statistical analysis of the resulting mini-peptidome. Partial automation provides reproducibility and throughput essential for comparing large sample sets. The approach may be used for diagnostic or predictive purposes and it enables profiling of 96 samples in 30 h. It could be tailored to many diagnostic and pharmaco-dynamic purposes as a readout of catalytic and metabolic activities in body fluids or tissues.
引用
收藏
页码:1167 / 1183
页数:17
相关论文
共 50 条
  • [1] Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry
    Josep Villanueva
    Arpi Nazarian
    Kevin Lawlor
    Paul Tempst
    Nature Protocols, 2009, 4 : 1167 - 1183
  • [2] MALDI-TOF mass spectrometry
    Butler, JM
    PROGRESS IN FORENSIC GENETICS 8, 2000, (1193): : 15 - 18
  • [3] Analysis of complex polymers by MALDI-TOF mass spectrometry
    Pasch, H
    Ghahary, R
    MACROMOLECULAR SYMPOSIA, 2000, 152 : 267 - 278
  • [4] Discrimination of Normal and Esophageal Cancer Plasma Proteomes by MALDI-TOF Mass Spectrometry
    Schwacke, John
    Millar, Timothy P.
    Hammond, Charles E.
    Saha, Arindam
    Hoffman, Brenda J.
    Romagnuolo, Joseph
    Hill, Elizabeth G.
    Smolka, Adam J.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (06) : 1645 - 1654
  • [5] Discrimination of Normal and Esophageal Cancer Plasma Proteomes By MALDI-TOF Mass Spectrometry
    Schwacke, John
    Millar, Timothy P.
    Hammond, Charles E.
    Hill, Elizabeth G.
    Saha, Arindam
    Hoffman, Brenda J.
    Smolka, Adam J.
    GASTROENTEROLOGY, 2009, 136 (05) : A751 - A751
  • [6] Discrimination of Normal and Esophageal Cancer Plasma Proteomes by MALDI-TOF Mass Spectrometry
    John Schwacke
    Timothy P. Millar
    Charles E. Hammond
    Arindam Saha
    Brenda J. Hoffman
    Joseph Romagnuolo
    Elizabeth G. Hill
    Adam J. Smolka
    Digestive Diseases and Sciences, 2015, 60 : 1645 - 1654
  • [7] Monitoring the enzymatic polymerization by MALDI-TOF mass spectrometry.
    Xu, P
    Kumar, J
    Samuelson, L
    Cholli, AL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U529 - U530
  • [8] MALDI-TOF mass spectrometry of bacteria
    Lay, JO
    MASS SPECTROMETRY REVIEWS, 2001, 20 (04) : 172 - 194
  • [9] Mass spectrometry MALDI-TOF for identification of the Candida parapsilosis complex
    Iranzo, A.
    Garcia-Effron, G.
    Peman, J.
    Canton, E.
    Lopez-Hontangas, J. L.
    MYCOSES, 2011, 54 : 180 - 181
  • [10] Monitoring the expression and purification of recombinant proteins by MALDI-TOF mass spectrometry
    Villanueva, J
    Canals, F
    Querol, E
    Avilés, X
    ENZYME AND MICROBIAL TECHNOLOGY, 2001, 29 (01) : 99 - 103